Koycheva Reneta Yovcheva, Cholakov Vasil, Andreev Jivko, Penev Margarit, Iliev Rosen, Nancheva Krasimira, Tsoneva Vanya
Department of Nephrology, University Hospital "Prof. Dr. Stoyan Kirkovich", Stara Zagora, Bulgaria.
Open Access Maced J Med Sci. 2016 Mar 15;4(1):59-64. doi: 10.3889/oamjms.2016.011. Epub 2015 Dec 30.
Cardiac biomarkers are often elevated in dialysis patients showing the presence of left ventricular dysfunction. The aim of the study is to establish the plasma levels of high-sensitivity cardiac troponin T (hs TnT), precursor of B-natriuretic peptide (NT-proBNP) and high sensitivity C-reactive protein (hs CRP) and their relation to the presence of left ventricular hypertrophy (LVH) in patients undergoing hemodialysis without signs of acute coronary syndrome or heart failure.
We studied 48 patients - 26 men and 22 women. Pre and postdialysis levels of hs cTnT, NT-proBNP and hs CRP were measured at week interim procedure. Patients were divided in two groups according to the presence of echocardiographic evidence of LVH - gr A - 40 patients (with LVH), and gr B - 8 patients (without LVH).
In the whole group of patients was found elevated predialysis levels of all three biomarkers with significant increase (p < 0.05) after dialysis with low-flux dialyzers. Predialysis values of NT-proBNP show moderate positive correlation with hs cTnT (r = 0.47) and weaker with hs CRP (r = 0.163). Such dependence is observed in postdialysis values of these biomarkers. There is a strong positive correlation between the pre and postdialysis levels: for hs cTnT (r = 0.966), for NT-proBNP (r = 0.918) and for hs CRP (r = 0.859). It was found a significant difference in the mean values of hs cTnT in gr. A and gr. B (0.07 ± 0.01 versus 0.03 ± 0.01 ng/mL, p < 0.05) and NT-proBNP (15,605.8 ± 2,072.5 versus 2,745.5 ± 533.55 pg/mL, p < 0.05). Not find a significant difference in hs CRP in both groups.
The results indicate the relationship of the studied cardiac biomarkers with LVH in asymptomatic patients undergoing hemodialysis treatment.
透析患者的心脏生物标志物通常会升高,提示存在左心室功能障碍。本研究的目的是确定接受血液透析且无急性冠状动脉综合征或心力衰竭迹象的患者血浆中高敏心肌肌钙蛋白T(hs TnT)、B型利钠肽前体(NT-proBNP)和高敏C反应蛋白(hs CRP)的水平及其与左心室肥厚(LVH)的关系。
我们研究了48例患者,其中男性26例,女性22例。在每周的中间程序中测量透析前和透析后hs cTnT、NT-proBNP和hs CRP的水平。根据超声心动图显示的LVH证据将患者分为两组——A组40例(有LVH),B组8例(无LVH)。
在整个患者组中,发现所有三种生物标志物的透析前水平均升高,使用低通量透析器透析后显著升高(p < 0.05)。NT-proBNP的透析前值与hs cTnT呈中度正相关(r = 0.47),与hs CRP的相关性较弱(r = 0.163)。在这些生物标志物的透析后值中也观察到这种相关性。透析前和透析后水平之间存在强正相关:hs cTnT为(r = 0.966),NT-proBNP为(r = 0.918),hs CRP为(r = 0.859)。发现A组和B组hs cTnT的平均值存在显著差异(0.07 ± 0.01对0.03 ± 0.01 ng/mL,p < 0.05),NT-proBNP也有显著差异(15,605.8 ± 2,072.5对2,745.5 ± 533.55 pg/mL,p < 0.05)。两组hs CRP未发现显著差异。
结果表明所研究的心脏生物标志物与接受血液透析治疗的无症状患者的LVH有关。